Advanced Search

Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3)

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging

A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413

Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3)

RADIOPHARMACOLOGY - RECENT DEVELOPMENTS IN THE FIELD OF RADIOPHARMACEUTICALS 

     EDITORIAL

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):239-40

Radiopharmacology: recent developments in the field of radiopharmaceuticals

Cutler C. S.


     REVIEWS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):241-68

Prostate-specific membrane antigen as a target for cancer imaging and therapy

Kiess A. P., Banerjee S. R., Mease R. C., Rowe S. P., Rao A., Foss C. A., Chen Y., Yang X., Cho S. Y., Nimmagadda S., Pomper M. G.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):269-86

Preclinical development of small-molecular-weight folate-based radioconjugates: a pharmacological perspective

Siwowska K., Müller C.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):287-302

Radiolabeled gastrin/CCK analogs in tumor diagnosis: towards higher stability and improved tumor targeting

Kaloudi A., Nock B. A., Krenning E. P., Maina T., De Jong M.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):303-16

Preclinical imaging and treatment of cancer: the use of animal models beyond rodents

Axiak-Bechtel S. M., Maitz C. A., Selting K. A., Bryan J. N.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):317-26

Preclinical testing of radiopharmaceuticals for novel applications in HIV, bacterial and fungal infectious diseases

Shah M., Garg G., Dadachova E.


     ORIGINAL ARTICLES

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):327-35

Detection of extranodal spread in head and neck cancer with [18F]FDG PET and MRI: improved accuracy?

Lodder W. L., Vogel W. V., Lange C. A., Hamming-Vrieze O., Van Velthuysen M.-L., Pameijer F. A., Balm A. J., Van Den Brekel M. W.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):336-41

Estimation of coronary flow reserve by sestamibi imaging in patients with mild hypertension and normal coronary arteries

Storto G., Gallicchio R., Maddalena F., Pellegrino T., Petretta M., Fiumara G., Cuocolo A.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):342-50

11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning

Garcia J. R., Jorcano S., Soler M., Linero D., Moragas M., Riera E., Miralbell R., Lomeña F.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):351-6

A bone metastases model of anaplastic thyroid carcinoma in athymic nude mice

Zhang L., Wang H., Liang S., Ma C.


top of page